The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
trimipramine · Capsule
6 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Tricyclic Antidepressant, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- clomipramine hydrochloride capsules· 1 maker
- desipramine· 1 maker
- doxepn hydrochloride· 1 maker
- nortriptyline hcl· 1 maker
- perphenazine and amitriptyline hydrochloride· 1 maker
- chlordiazepoxide and amitriptyline hydrochloride· 2 makers
- desipramine hcl· 2 makers
- amoxapine· 3 makers
- doxepin hcl· 3 makers
- imipramine pamoate· 4 makers
- protriptyline hydrochloride· 4 makers
- trimipramine maleate· 4 makers
Common questions
- Is Trimipramine in shortage right now?
- No. FDA does not currently list Trimipramine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Trimipramine?
- 1 company has marketed Trimipramine in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.